📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Resistance to ERK1/2 pathway inhibitors; sweet spots, fitness deficits and drug addiction. (2019)

First Author: Sale MJ

Attributed to: To define the molecular mechanisms that determine cellular and organismal longevity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.20517/cdr.2019.14

PubMed Identifier: 35582726

Publication URI: http://europepmc.org/abstract/MED/35582726

Type: Journal Article/Review

Volume: 2

Parent Publication: Cancer drug resistance (Alhambra, Calif.)

Issue: 2

ISSN: 2578-532X